Spero Therapeutics, Inc.
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2015 | — | $-13.3M | $-10.2M |
| FY2016 | $335.0K | $-33.2M | $-25.5M |
| FY2017 | $2.0M | $-41.7M | $-38.7M |
| FY2018 | $4.0M | $-42.8M | $-41.7M |
| FY2019 | $18.1M | $-63.2M | $-60.9M |
| FY2020 | $9.3M | $-79.1M | $-78.3M |
| FY2021 | $18.3M | $-88.0M | $-89.8M |
| FY2022 | $53.5M | $-42.2M | $-46.4M |
| FY2023 | $103.8M | $21.5M | $22.8M |
| FY2024 | $48.0M | $-73.4M | $-68.6M |
| FY2025 | $66.8M | $6.3M | $8.6M |
The stock investor is neither right or wrong because others agreed or disagreed with him; he is right because his facts and analysis are right.